Johnson & Johnson Collaborates With China MOH On Cardiology Training And Authentication
This article was originally published in PharmAsia News
Johnson & Johnson Medical (China) and International Health Exchange and Cooperation Center under China's Ministry of Health have signed an agreement on Chinese physician training for cardiology intervention diagnosis and treatment. Sponsored by Johnson & Johnson and guided by the ministry's Medical Administration Department, the three-year program will conduct standardized training and authentication for local cardiology intervention physicians. Johnson & Johnson's Cordis College and MOH will jointly establish a training system for cardiology diseases, complemented by physician practice license authentication. The uniquely Chinese program will be standardized and systematic, in line with international practices, so as to promote medical quality and ensure safety. (Click here for more - Chinese language)
You may also be interested in...
Firm supplying all-in-one multivitamin blends rather than packs of multiple pills has four-member advisory board including digital marketing and consumer product marketing specialists and a health care strategist.
UK-headquartered company gets further backing from Novo Ventures and other investors convinced of the potential of NLRP3 inhibitors.
Mylan and Pfizer’s Upjohn have revealed a key date for their merger to create Viatris, after the deal set for midway through the year was pushed back recently due to the coronavirus pandemic.